Back to search

Article

Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6

2023-05-25

Abstract excerpt

<h4>ABSTRACT</h4> Human papillomavirus (HPV) infections account for nearly all cervical cancer cases, which is the fourth most common cancer in women worldwide. High-risk variants, including HPV16, drive tumorigenesis in part by promoting the degradation of the tumor suppressor p53. This degradation is mediated by the HPV early protein 6 (E6), which recruits the E3 ubiquitin ligase E6AP and redirects its activity...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c25e055f-d4b7-5b5b-9827-b8d9a5a2e5d3
DOI
10.1101/2023.05.25.542341
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6DOI 10.1101/2023.05.25.542341
Select a neighboring publication to make it the new centre.